Key points are not available for this paper at this time.
Design
Review
Recognizing lipid triad predominance in metabolic syndrome may inform dyslipidemia assessment; leaves open causal validation and targeted trials.
Metabolic syndrome is a complex of metabolic, hormonal and clinical disorders that are risk factors for the development of cardiovascular diseases, which are based on insulin resistance and compensatory hyperinsulinemia. The main mechanisms of the effects of chronic hyperinsulinemia on blood pressure are given, and the main symptoms and manifestations of the metabolic syndrome are given. The most common variant of dyslipidemia in the metabolic syndrome is the lipid triad.
No takes yet. Share an insight, caveat, or question.
Туркина et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: